SGLT2 inhibitors in diabetic kidney disease
Christos Argyropoulos, M.D. Ph.D. FASN
Assistant Professor, Division Chief Nephrology Department of Internal Medicine, School of Medicine, University of New Mexico
Видео SGLT2 inhibitors in diabetic kidney disease канала Glomerular Disease Study & Trial Consortium
Assistant Professor, Division Chief Nephrology Department of Internal Medicine, School of Medicine, University of New Mexico
Видео SGLT2 inhibitors in diabetic kidney disease канала Glomerular Disease Study & Trial Consortium
Показать
Комментарии отсутствуют
Информация о видео
31 августа 2020 г. 19:28:25
01:34:11
Другие видео канала
COVID-19 Associated Renal Disease: Pathology and New Molecular Insights
SGLT2 Inhibitors in Patients Without Diabetes at Risk of HF
Diabetes medications - SGLT 2 inhibitors
The Kidney in Aging and the Diagnosis of CKD
New Glucose-Lowering Drugs and Kidney Protection in CKD
ABC's of Kidney Disease
Using SGLT2-inhibitors to treat cardiac patients with diabetes
Diabetic Nephropathy for USMLE Step1 and USMLE Step 2
Pneumonia Explained Clearly by MedCram.com
Highlight on Dapagliflozin in Patients with Chronic Kidney Disease.prof. Amr El-Husseini,24 Sep 2020
CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21
How does Dapagliflozin work? Understanding SGLT2 inhibitors.
Why is the Diagnosis of “Hypertensive Nephrosclerosis” a Fallacy and a Cop-out?
Assessing Kidney Function: Glomerular Filtration Rate (GFR): Nephrology| Lecturio
How to Reverse Type 2 Diabetes Naturally | Jason Fung
Chronic Kidney Disease - CRASH! Medical Review Series
Educational webinar: New treatments for preventing chronic kidney disease progression
Glomerulonephritis with Dr. Caster
Type 2 Diabetes: The Benefits and Cost-Effectiveness of SGLT2 Inhibitors
Pauci-immune Glomerulonephritis: Overview and Updates